CJC/IPA 10MG/10MG
$70.00 $49.0030% OFF
CJC-1295 (No DAC) / Ipamorelin 10mg / 10mg
Dual peptide blend studied for coordinated GHRH and ghrelin receptor activity within growth hormone regulatory research models.
- 10mg CJC-1295 (No DAC)
- 10mg Ipamorelin
- Dual GH pathway research
- For research use only
Out of stock
CJC-1295 (No DAC) / Ipamorelin 10mg / 10mg
Dual peptide research blend studied for growth hormone pathway signaling and pituitary receptor activity.
Compound Overview
This research formulation combines CJC-1295 (No DAC), a synthetic analogue of growth hormone–releasing hormone (GHRH), with Ipamorelin, a selective growth hormone secretagogue. Together, these peptides are studied in laboratory settings for their coordinated interaction within endogenous growth hormone regulatory pathways.
CJC-1295 (No DAC) targets GHRH receptors in the anterior pituitary to stimulate pulsatile growth hormone release in controlled experimental models. Ipamorelin acts as a ghrelin receptor (GHS-R1a) agonist, evaluated for its role in stimulating growth hormone secretion through a separate but complementary receptor pathway. Combination research often examines dual-pathway stimulation and endocrine signaling dynamics.
CJC-1295 Research Focus
Studied for GHRH receptor activation, pulsatile GH release models, and pituitary-endocrine feedback research.
Ipamorelin Research Focus
Evaluated as a ghrelin receptor agonist for selective growth hormone stimulation in experimental endocrine pathway models.
Combination Research Applications
Included in studies examining coordinated GHRH and ghrelin receptor signaling within growth hormone regulation systems.
Product Specifications
- Product Name: CJC-1295 (No DAC) / Ipamorelin Blend
- CJC-1295 Content: 10mg
- Ipamorelin Content: 10mg
- Total Peptide Content: 20mg per vial
- Form: Lyophilized peptide powder blend
- Intended Use: Research use only
Be the first to review “CJC/IPA 10MG/10MG”
Related products
Reviews
There are no reviews yet.